tiprankstipranks
Trending News
More News >
Adaptimmune Therapeutics Plc. (ADAP)
:ADAP
US Market

Adaptimmune Therapeutics (ADAP) Ownership - Who Owns Adaptimmune Therapeutics?

Compare
896 Followers

Adaptimmune Therapeutics (ADAP) Ownership Overview

47.53%0.20%0.09%0.25%51.93%
47.53% Insiders
0.09% Other Institutional Investors
0.25% ETFs
51.93% Public Companies and Individual Investors
The ownership structure of Adaptimmune Therapeutics (ADAP) stock is a mix of institutional, retail, and individual investors. Approximately 0.53% of the company’s stock is owned by Institutional Investors, 47.53% is owned by Insiders, and 51.93% is owned by Public Companies and Individual Investors.
The ownership structure of Adaptimmune Therapeutics (ADAP) stock is a mix of institutional, retail, and individual investors. Approximately 0.29% of the company’s stock is owned by Institutional Investors, 47.53% is owned by Insiders, and 0.25% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$17192

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
102,478,668Insider38.66%26,029,582
37,681,515Institution14.22%9,571,105
19,500,000Insider7.36%4,953,000
2,343,695Institution0.88%595,299
425,388Institution0.16%108,049
246,744Institution0.09%62,673
139,801Institution0.05%35,509
130,764Insider0.05%33,214
122,621Institution0.05%31,146
99,822Institution0.04%25,355

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
246,744Institution0.09%62,673
139,801Institution0.05%35,509
99,822Institution0.04%25,355
16,257Institution<0.01%4,129
6,385Institution<0.01%1,622
554Institution<0.01%141

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
285,179Institution0.11%69,099
140,209Institution0.05%33,973
122,413Institution0.05%29,661
80,548Institution0.03%20,475

FAQ

Who Owns Adaptimmune Therapeutics Plc. (ADAP)?
According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 47.53% is held by insiders, and 51.93% is held by retail investors.
    What percentage of Adaptimmune Therapeutics Plc. (ADAP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.09% of Adaptimmune Therapeutics Plc. (ADAP) stock is held by institutional investors.
      What percentage of Adaptimmune Therapeutics Plc. (ADAP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 51.93% of Adaptimmune Therapeutics Plc. (ADAP) stock is held by retail investors.
        Who owns the most shares of Adaptimmune Therapeutics Plc. (ADAP)?
        David Mott owns the most shares of Adaptimmune Therapeutics Plc. (ADAP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis